Skip to main content
SpringerLink
Log in

Diagnosis, Preoperative Evaluation, and Assessment of Resectability of Pancreatic and Periampullary Cancer

  • Original Article
  • Published:
Indian Journal of Surgery Aims and scope Submit manuscript

Abstract

Periampullary region encircles a radius of 2 cm around the ampulla of Vater; accordingly, four distinct neoplasias with overlapping imaging features originate in the region. Each of these lesions has a different long-term prognosis; hence, imaging evaluation to characterize the lesion is important. Further certain specific features pertaining to the vascular invasion and systemic spread may decide about the treatment as well as surgical approach. An understanding of the advances in imaging and image processing technology as well as in the methods of image acquisition, for the purpose, is quite relevant towards etching out a rational pre-treatment evaluation protocol. Further, an evidence-based decision as to the choice of optimum modality for answering specific clinical question is of prime importance in achieving a reasonable post-treatment outcome. Pancreatic adenocarcinoma is the fourth most common cancer and a malignancy with one of the least 5-year survival rates (ranging from 6.8 to 15 % depending on peripancreatic extensions, dropping to 1.8 % for metastatic disease). A survival rate of 15–27 % can be achieved if the lesion is resectable but unfortunately, only 10–15 % of patients are eligible for resection. Cystic tumors of pancreas are a rarer variety of pancreatic neoplasia (5–15 % of pancreatic cysts and 1 % of all pancreatic cancers) which have a much better outcome and chances of resection. Being mostly incidentalomas, a timely differentiation of this lesion from the much more common pseudocyst (which would mandate a medical management and a different surgical protocol) is the key for curability. Lastly, the neuroendocrine tumors of pancreas are equally rare (1 % of all pancreatic tumors), but importantly due to associated clinical syndromes and their capability to metastasize early in the course of disease, a timely detection may hence be the key for successful treatment of these lesions. Imaging plays a vital role in the initial detection and characterization as well as in determination of resectability of each of these pancreatic neoplasias. Further, the differentiation of pancreatic head tumors from other periampullary neoplasias is important; the fact that most recurrences are as a result of surgical intervention in an otherwise inoperable disease while most treatment failures are due to improper characterization of the lesion is notable.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Kim SY, Lee JM, Kim SH, Shin KS, Kim YJ, An SK et al (2006) Macrocystic neoplasms of the pancreas: CT differentiation of serous oligocystic adenoma from mucinous cystadenoma and intraductal papillary mucinous tumor. AJR Am J Roentgenol 187:1192–1198

    Article  PubMed  Google Scholar 

  2. Park MS, Kim KW, Lim JS, Lee JH, Kim JH, Kim SY et al (2005) Unusual cystic neoplasms in the pancreas: radiologicpathologic correlation. J Comput Assist Tomogr 29:610–616

    Article  PubMed  Google Scholar 

  3. Irie H, Honda H, Aibe H, Kuroiwa T, Yoshimitsu K, Shinozaki K et al (2000) MR cholangiopancreatographic differentiation of benign and malignant intraductal mucin-producing tumors of the pancreas. AJR Am J Roentgenol 174:1403–1408

    Article  PubMed  CAS  Google Scholar 

  4. Song SJ, Lee JM, Kim YJ, Kim SH, Lee JY, Han JK et al (2007) Differentiation of intraductal papillary mucinous neoplasms from other pancreatic cystic masses: comparison of multirowdetector CT and MR imaging using ROC analysis. J Magn Reson Imaging 26:86–93

    Article  PubMed  Google Scholar 

  5. Sahani DV, Kadavigere R, Saokar A, Fernandez-del Castillo C, Brugge WR, Hahn PF (2005) Cystic pancreatic lesions: a simple imaging-based classification system for guiding management. Radiographics 25:1471–1484

    Article  PubMed  Google Scholar 

  6. Cho H-W, Choi J-Y, Kim M-J, Park M-S, Lim JS, Chung YE, Kim KW (2011) Pancreatic tumors: emphasis on CT findings and pathologic classification. KJR 12(6):731–739

    Article  Google Scholar 

  7. Nikolaidis P, Hammond NA, Day K, Yaghmai V, Wood CG 3rd, Mosbach DS, Harmath CB, Taffel MT, Horowitz JM, Berggruen SM, Miller FH (2014) Imaging features of benign and malignant ampullary and periampullary lesions. Radiographics 34(3):624–641

    Article  PubMed  Google Scholar 

  8. Wiersema MJ, Wiersema LM (1996) Endosonography guided celiac plexus neurolysis. Gastrointest Endosc 44:656–662

    Article  PubMed  CAS  Google Scholar 

  9. Wong GY, Schroeder DR, Carns PE, Wilson JL, Martin DP, Kinney MO, Carlos BM, Warner DO (2004) Effect of neurolytic celiac plexus block on pain relief, quality of life, and survival in patients with unresectable pancreatic cancer—a randomized controlled trial. JAMA 291(9):1092–1099

    Article  PubMed  CAS  Google Scholar 

  10. Wyse JM, Chen YI, Sahai AV (2014) Celiac plexus neurolysis in the management of unresectable pancreatic cancer: when and how? World J Gastroenterol 20(9):2186–2192

    Article  PubMed  PubMed Central  Google Scholar 

  11. Papadopoulos D, Kostopanagiotou G, Batistaki C (2013) Bilateral thoracic splanchnic nerve radiofrequency thermocoagulation for the management of end-stage pancreatic abdominal cancer pain. Pain Physician 16:125–133

    PubMed  Google Scholar 

  12. Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA Cancer J Clin 64(1):9–29

    Article  PubMed  Google Scholar 

  13. Arnold LD, Patel AV, Yan Y, Jacobs EJ, Thun MJ, Calle EE, Colditz GA (2009) Are racial disparities in pancreatic cancer explained by smoking and overweight/obesity? Cancer Epidemiol Biomarkers Prev 18(9):2397–2405

    Article  PubMed  PubMed Central  Google Scholar 

  14. Simard EP, Ward EM, Siegel R, Jemal A (2012) Cancers with increasing incidence trends in the United States: 1999 through 2008. CA Cancer J Clin 62(2):118–128

    Article  PubMed  Google Scholar 

  15. Smith BD, Smith GL, Hurria A, Hortobagyi GN, Buchholz TA (2009) Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol 27(17):2758–2765

    Article  PubMed  Google Scholar 

  16. Visser BC, Ma Y, Zak Y, Poultsides GA, Norton JA, Rhoads KF (2012) Failure to comply with NCCN guidelines for the management of pancreatic cancer compromises outcomes. HPB (Oxford) 14(8):539–547

    Article  Google Scholar 

  17. Rijkers AP, Valkema R, Duivenvoorden HJ, van Eijck CH (2014) Usefulness of F-18-fluorodeoxyglucose positron emission tomography to confirm suspected pancreatic cancer: a meta-analysis. Eur J Surg Oncol 40(7):794–804

    Article  PubMed  CAS  Google Scholar 

  18. Rösch T, Braig C, Gain T, Feuerbach S, Siewert JR, Schusdziarra V, Classen M (1992) Staging of pancreatic and ampullary carcinoma by endoscopic ultrasonography. Comparison with conventional sonography, computed tomography, and angiography. Gastroenterology 102(1):188–199

    PubMed  Google Scholar 

  19. Varadarajulu S, Wallace MB (2004) Applications of endoscopic ultrasonography in pancreatic cancer. Cancer Control 11(1):15–22

    PubMed  Google Scholar 

  20. Fuhrman GM, Charnsangavej C, Abbruzzese JL, Cleary KR, Martin RG, Fenoglio CJ, Evans DB (1994) Thin-section contrast-enhanced computed tomography accurately predicts the resectability of malignant pancreatic neoplasms. Am J Surg 167(1):104–111

    Article  PubMed  CAS  Google Scholar 

  21. Horton KM, Fishman EK (2002) Adenocarcinoma of the pancreas: CT imaging. Radiol Clin N Am 40(6):1263–1272

    Article  PubMed  Google Scholar 

  22. House MG, Yeo CJ, Cameron JL, Campbell KA, Schulick RD, Leach SD, Hruban RH, Horton KM, Fishman EK, Lillemoe KD (2004) Predicting resectability of periampullary cancer with three-dimensional computed tomography. J Gastrointest Surg 8(3):280–288

    Article  PubMed  Google Scholar 

  23. Klauss M, Schöbinger M, Wolf I, Werner J, Meinzer HP, Kauczor HU, Grenacher L (2009) Value of three-dimensional reconstructions in pancreatic carcinoma using multidetector CT: initial results. World J Gastroenterol 15(46):5827–5832

    Article  PubMed  PubMed Central  Google Scholar 

  24. Günter S, Siveke JT, Eckel F, Schmid RM (2005) Pancreatic cancer: basic and clinical aspects. Gastroenterology 128:1606–1625

    Article  Google Scholar 

  25. Schima W, Ba-Ssalamah A, Goetzinger P, Scharitzer M, Koelblinger C (2007) State-of-the-art magnetic resonance imaging of pancreatic cancer. Top Magn Reson Imaging 18(6):421–429

    Article  PubMed  Google Scholar 

  26. Nallamothu G, Hilden K, Adler DG (2011) Endoscopic retrograde cholangiopancreatography for non-gastroenterologists: what you need to know. Hosp Pract (1995) 39(2):70–80

    Article  Google Scholar 

  27. Tirkes T, Sandrasegaran K, Sanyal R, Sherman S, Schmidt CM, Cote GA, Akisik F (2013) Secretin-enhanced MR cholangiopancreatography: spectrum of findings. Radiographics 33(7):1889–1906

    Article  PubMed  Google Scholar 

  28. Warshaw AL, Gu ZY, Wittenberg J, Waltman AC (1990) Preoperative staging and assessment of resectability of pancreatic cancer. Arch Surg 125(2):230–233

    Article  PubMed  CAS  Google Scholar 

  29. Andersson R, Vagianos CE, Williamson RC (2004) Preoperative staging and evaluation of resectability in pancreatic ductal adenocarcinoma. HPB (Oxford) 6(1):5–12

    Article  CAS  Google Scholar 

  30. Varadachary GR, Wolff RA, Crane CH et al (2008) Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head. J Clin Oncol 26:3487–3495

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiodiagnosis and Imaging, Institute of Medical Sciences, Banaras Hindu University, Varanasi, 221005, India

    Ashish Verma

  2. Department of Gastroenterology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, 221005, India

    Sunit Shukla

  3. Department of Anesthesiology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, 221005, India

    Nimisha Verma

Authors
  1. Ashish Verma
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sunit Shukla
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nimisha Verma
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ashish Verma.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Verma, A., Shukla, S. & Verma, N. Diagnosis, Preoperative Evaluation, and Assessment of Resectability of Pancreatic and Periampullary Cancer. Indian J Surg 77, 362–370 (2015). https://doi.org/10.1007/s12262-015-1370-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12262-015-1370-0

Keywords

Search

Navigation